eclipse vert.x

productUS

cpe:2.3:a:eclipse:vert.x:*:*:*:*:*:*:*:*

A product tracked in the threat graph; the vulnerabilities below are known to affect it.

0
KEV-listed
0
EPSS ≥ 10%
by severity
3critical5high19medium0low
updated 2026-10-28
01

vulnerabilities (27)

Related CVEs.

IDseverity exploitable
CVE-2018-12537USmedium5.3Exploit
CVE-2018-12542UScritical9.8Exploit
CVE-2019-17640UScritical9.8Exploit
CVE-2018-12540UShigh8.8Exploit
CVE-2018-12541USmedium6.5—
CVE-2018-12544UScritical9.8—
CVE-2024-8391UShigh7.5—
CVE-2025-11965UShigh7.5—
CVE-2026-102469USmedium5.9—
CVE-2026-102461USmedium5.9—
CVE-2026-103224USmedium5.9—
CVE-2026-103223USmedium5.9—
CVE-2026-102462USmedium5.9—
CVE-2026-102477USmedium5.9—
CVE-2026-102471USmedium5.9—
CVE-2026-102464USmedium5.9—
CVE-2026-102463USmedium5.9—
CVE-2025-11966USmedium6.4—
CVE-2026-102466USmedium5.9—
CVE-2026-102460USmedium5.9OT elevated—
CVE-2026-102479USmedium5.9—
CVE-2026-102475USmedium5.9—
CVE-2026-102467USmedium5.9—
CVE-2026-6860USmedium5.3—
CVE-2026-102465USmedium5.9—
CVE-2026-15076UShigh7.5—
CVE-2026-15075UShigh7.5—
02

weaknesses (8)

The flaw types (CWEs) most of these CVEs share.

  • CWE-770Allocation of Resources Without Limits or Throttling6 CVEs
  • CWE-789Memory Allocation with Excessive Size Value5 CVEs
  • CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')2 CVEs
  • CWE-346Origin Validation Error2 CVEs
  • CWE-93Improper Neutralization of CRLF Sequences ('CRLF Injection')2 CVEs
  • CWE-119Improper Restriction of Operations within the Bounds of a Memory Buffer1 CVEs
  • CWE-20Improper Input Validation1 CVEs
  • CWE-200Exposure of Sensitive Information to an Unauthorized Actor1 CVEs
03

sources (1)

Which sources assert this record, and when.

scry

Products carry known vulnerabilities once they are exposed to the internet. See what is exposed on your perimeter with a free passive scan.

Free scan